Sexual dysfunction and its impact on quality of life in Chinese patients with schizophrenia treated in primary care

Compr Psychiatry. 2016 Feb:65:116-21. doi: 10.1016/j.comppsych.2015.11.002. Epub 2015 Nov 14.

Abstract

Purpose: Sexual dysfunction in schizophrenia patients is common. In China, maintenance treatment for clinically stable patients with schizophrenia is usually provided by primary care physicians. Illness- or treatment-related sexual dysfunction in this patient population has been never studied. This study describes the prevalence and correlates of sexual dysfunction and its impact on quality of life (QOL) in patients with schizophrenia treated in primary care in China.

Method: A total of 607 patients with schizophrenia treated in 22 randomly selected primary care services in China formed the study sample. Patients' socio-demographic and clinical characteristics including sexual function and QOL were recorded using a standardized protocol and data collection.

Results: Sexual dysfunction was present in 69.9% of all patients; 60.7% in males and 80.6% in females. Multiple logistic regression analysis revealed that female gender, being single, older age and use of first-generation antipsychotics were independently and significantly associated with more sexual dysfunction accounting for 23.5% of its variance (P<0.001). Unexpectedly, sexual dysfunction was not associated with lower QOL.

Conclusions: High rate of sexual dysfunction was reported in the majority of patients with schizophrenia treated in primary care in China. Given its negative impact on social adjustment, QOL and treatment adherence, efforts should be made to address sexual dysfunction in this patient population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antipsychotic Agents / therapeutic use
  • Asian People / psychology*
  • Asian People / statistics & numerical data
  • China / epidemiology
  • Comorbidity
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Primary Health Care*
  • Quality of Life*
  • Schizophrenia / drug therapy*
  • Schizophrenia / epidemiology*
  • Schizophrenic Psychology*
  • Sexual Dysfunction, Physiological / epidemiology*
  • Sexual Dysfunction, Physiological / psychology
  • Sexual Dysfunctions, Psychological / epidemiology*
  • Sexual Dysfunctions, Psychological / psychology

Substances

  • Antipsychotic Agents